chr19-7145620-G-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000208.4(INSR):​c.2268-2530C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0444 in 152,280 control chromosomes in the GnomAD database, including 907 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.044 ( 907 hom., cov: 33)

Consequence

INSR
NM_000208.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0820

Publications

1 publications found
Variant links:
Genes affected
INSR (HGNC:6091): (insulin receptor) This gene encodes a member of the receptor tyrosine kinase family of proteins. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that form a heterotetrameric receptor. Binding of insulin or other ligands to this receptor activates the insulin signaling pathway, which regulates glucose uptake and release, as well as the synthesis and storage of carbohydrates, lipids and protein. Mutations in this gene underlie the inherited severe insulin resistance syndromes including type A insulin resistance syndrome, Donohue syndrome and Rabson-Mendenhall syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]
INSR Gene-Disease associations (from GenCC):
  • insulin-resistance syndrome type A
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, G2P
  • Donohue syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P
  • hyperinsulinism due to INSR deficiency
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, Ambry Genetics
  • Rabson-Mendenhall syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.73).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.483 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
INSRNM_000208.4 linkc.2268-2530C>G intron_variant Intron 11 of 21 ENST00000302850.10 NP_000199.2 P06213-1
INSRNM_001079817.3 linkc.2232-2530C>G intron_variant Intron 10 of 20 NP_001073285.1 P06213-2
INSRXM_011527988.3 linkc.2268-2530C>G intron_variant Intron 11 of 21 XP_011526290.2
INSRXM_011527989.4 linkc.2232-2530C>G intron_variant Intron 10 of 20 XP_011526291.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
INSRENST00000302850.10 linkc.2268-2530C>G intron_variant Intron 11 of 21 1 NM_000208.4 ENSP00000303830.4 P06213-1
INSRENST00000341500.9 linkc.2232-2530C>G intron_variant Intron 10 of 20 1 ENSP00000342838.4 P06213-2

Frequencies

GnomAD3 genomes
AF:
0.0443
AC:
6743
AN:
152164
Hom.:
903
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00827
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.166
Gnomad ASJ
AF:
0.00432
Gnomad EAS
AF:
0.498
Gnomad SAS
AF:
0.0591
Gnomad FIN
AF:
0.0608
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00390
Gnomad OTH
AF:
0.0334
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0444
AC:
6759
AN:
152280
Hom.:
907
Cov.:
33
AF XY:
0.0525
AC XY:
3912
AN XY:
74450
show subpopulations
African (AFR)
AF:
0.00835
AC:
347
AN:
41572
American (AMR)
AF:
0.167
AC:
2548
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.00432
AC:
15
AN:
3470
East Asian (EAS)
AF:
0.499
AC:
2585
AN:
5180
South Asian (SAS)
AF:
0.0585
AC:
282
AN:
4820
European-Finnish (FIN)
AF:
0.0608
AC:
645
AN:
10610
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00390
AC:
265
AN:
68024
Other (OTH)
AF:
0.0336
AC:
71
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
250
500
749
999
1249
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
72
144
216
288
360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0200
Hom.:
33
Bravo
AF:
0.0537
Asia WGS
AF:
0.234
AC:
810
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.73
CADD
Benign
8.7
DANN
Benign
0.81
PhyloP100
0.082
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12461909; hg19: chr19-7145631; API